Supplementary figure 1 A. Ctrl PB b III Tubulin F actin Hoechst * B.

Slides:



Advertisements
Similar presentations
Supplementary Figure 1. Caspase 8 expression and activation and Fas expression in NSCLC and normal lung cell lines. A Western blot analysis of DR4 and.
Advertisements

SKOV-3, 48h CaOV-3, 48h BG-1, 48h Concentration (µM) Viable cells (%) SW 43 SW IV-52s SW III-123 SW 43 + SW IV-52s SW 43 SW IV-52s SW III-123 SW 43 + SW.
A375A375R2 Vemurafenib (µM) BRAF (Full Length) p61-BRAF Isoform pMEK pERK Tubulin Supplementary Figure S
P-ERK β-tubulin VSShh + cyclopamine Supplementary Figure ESM 1a ERK MAP Kinase activity is not affected by Shh pathway activity. Western blot analysis.
Supplementary Figure 1. Characterization of NPC1 knockdown hESC lines. (A) Knockdown of NPC1 measured by qRT-PCR in four clonal NPC1 hESC lines. NPC1 levels.
Adipose PancreasAorta MuscleHeart Liver LungKidney Testis Spleen Brian 18S p55 γ p55 α Figure S1 Tissue distribution of p55 . (A) Representative RT-PCR.
Supplementary Figure S1 Cell index hours Cell index hours MiaPaca-2 cells vehicle ABTL0812 A549 cells.
Supplementary Fig. 1. RT-PCR showed that tumor tissues have elevated Mst1 mRNA levels in most of the HCC patients tested. GAPDH RT-PCR products were shown.
Supplementary Figure S4
Takehiko Wada, Jeffrey W. Pippin, Yoshio Terada, Stuart J. Shankland 
AntimiR-30b Inhibits TNF-α Mediated Apoptosis and Attenuated Cartilage Degradation through Enhancing Autophagy Cell Physiol Biochem 2016;40:
Volume 3, Issue 4, Pages (October 2014)
A B % positive cells 10 % positive cells 10 5 Gy 5 Gy Figure S3
Supplemental Digital Content 4
A B C D % positive cells 10 % Apoptotic nuclei 10 Figure S5 PM
Jane L. Armstrong, David S. Hill, Christopher S
B c * a Supplementary Figure 1. NLRP1 knockdown suppresses tumor growth in vivo. (a) 1205Lu tumors with NLRP1 shRNA from Santa Cruz Biotechnology. (b)
Volume 63, Issue 6, Pages (September 2016)
Xiang Li, Feng Xu, Ekapun Karoopongse, A
Volume 137, Issue 2, Pages e2 (August 2009)
A. D. B. C. - ΔNP63α - β-Actin IMEC - SUM MDA-MB IMEC
Volume 128, Issue 7, Pages (June 2005)
Volume 50, Issue 3, Pages (May 2013)
Volume 11, Issue 1, Pages (July 2012)
Volume 138, Issue 1, Pages (January 2010)
Supplemental Figure S1 a b
A B Supplementary Figure 3
Volume 52, Issue 3, Pages (November 2013)
David X Liu, Lloyd A Greene  Neuron 
Baxβ: A Constitutively Active Human Bax Isoform that Is under Tight Regulatory Control by the Proteasomal Degradation Mechanism  Nai Yang Fu, Sunil K.
a b MCF-7 TR2 MCF-7 TR2 (Fold change) MTT Assay , (Fold change)
Volume 11, Issue 6, Pages (June 2012)
FLAG β-actin p53 SET M.w. kDa D β-actin p53 G9a
Volume 5, Issue 6, Pages (December 2015)
Volume 11, Issue 1, Pages (July 2012)
Supplementary Figure 2. Effect of IL-32 and siRNA of IL-32 on melanoma, colon and prostate cancer cell growth and apoptosis as well as IL-32 expression.
B A D C * * E F Panc-1 cells Figure S1 DNA ladder h
Supplementary Figure 1 RT-PCR BclxL mismatch sc35 Dox BclxS
Volume 11, Issue 4, Pages (October 2018)
Andreia F.R. Batista, José C. Martínez, Ulrich Hengst  Cell Reports 
P63 Is an Essential Proapoptotic Protein during Neural Development
Volume 3, Issue 4, Pages (October 2014)
SUMO Promotes HDAC-Mediated Transcriptional Repression
Volume 53, Issue 4, Pages (February 2007)
Supplementary Figure S1
Supplementary Figure 1 a b c d e 1 2 cGMP levels (pmol/ml) vehicle
Sema4D, the Ligand for Plexin B1, Suppresses c-Met Activation and Migration and Promotes Melanocyte Survival and Growth  Joanne Soong, Yulin Chen, Elina.
Supplementary Figure 1. A
Suppl. Fig. 2 A B Evaluation of FasL-induced apoptosis in BM-MSCs.
Supplementary Figure 1. Structure of amlexanox
Fig S1 Figure S1. Frequent mutation in clear cell renal cell carcinoma. Figure S1 shows the top 20 genes ordered by the occurrence of mutations from COSMIC.
Volume 41, Issue 4, Pages (February 2004)
Regulation of YAP by Mechanical Strain through Jnk and Hippo Signaling
Supplementary Figure 1 a b c i ii iii i ii iii i ii iii
Supplementary Figure S4
Volume 43, Issue 1, Pages (July 2011)
Volume 18, Issue 1, Pages (January 2010)
Yi Tang, Jianyuan Luo, Wenzhu Zhang, Wei Gu  Molecular Cell 
Hsp27 expression rescues PC12 cells and SCG neurons from JNK-induced cell death and elicits neurite outgrowth. Hsp27 expression rescues PC12 cells and.
Volume 17, Issue 4, Pages (April 2010)
Volume 13, Issue 12, Pages (December 2015)
Effect of M-cadherin RNAi and GSK-3β inhibition on myogenic differentiation of C2C12 myoblasts. Effect of M-cadherin RNAi and GSK-3β inhibition on myogenic.
Formation of the Androgen Receptor Transcription Complex
SiRNA directed at Ngn1 inhibited differentiation of inner ear stem cells to β-III tubulin-positive cells. a, Inner ear stem cells treated with siRNA to.
Effect of M-cadherin RNAi on apoptosis in confluent C2C12 myoblasts.
Volume 62, Issue 3, Pages (May 2016)
CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection of CXCR4 siRNAs. CXCR4 expression levels of MDA-MB-231 cells at 48 hours posttransfection.
Adhesion to fibronectin protects Mcl-1 knockdown cells from apoptosis.
c-IAP1 Cooperates with Myc by Acting as a Ubiquitin Ligase for Mad1
Repulsive Guidance Molecule-a Is Involved in Th17-Cell-Induced Neurodegeneration in Autoimmune Encephalomyelitis  Shogo Tanabe, Toshihide Yamashita  Cell.
Presentation transcript:

Supplementary figure 1 A. Ctrl PB b III Tubulin F actin Hoechst * B. 20 40 60 80 100 120 * B. H3 AcK9-14 b-actin 43 KD 17KD Ctrl 4h 8h 24h PB Average neurite length/cell (µm) Ctrl PB C. 160 ** 140 * Average neurite length/cell (µm) 120 100 80 60 ** ** ** 40 20 Ctrl TSA dbcAMP Ctrl TSA dbcAMP Actinomycin D

Ctrl TSA Ctrl TSA Supplementary figure 2 A. Hoechst β III Tubulin B.

Supplementary figure 3 A. ** ** ** Ctrl TSA PB dbcAMP B. * * * 120 ** ** 100 ** Average neurite length/cell (µm) 80 60 40 20 Ctrl TSA PB dbcAMP B. 120 * Ctrl TSA 100 * Average neurite length/cell (µm) * 80 60 40 20 Actinomycin D Flavopiridol b-actin 43 KD H3 AcK9-14 17 KD PDL Myelin C.

RT-PCR- arbitrary units Supplementary figure Supplementary figure 4 A. 120 RNAi CBP 100 RNAi p300 RNAi P/CAF 80 RT-PCR- arbitrary units 60 40 20 B. GFP-Scr CBP-p300 siRNA GFP-Scr P/CAF shRNA GFP Hoechst GFP P/CAF CBP Hoechst

Supplementary figure 4 C. GFP-Scr +TSA 1ng/ml CBP-p300 siRNA +TSA 1ng/ml GFP-Scr +TSA 1ng/ml P/CAF shRNA +TSA 1ng/ml GFP Hoechst GFP P/CAF CBP Hoechst 120 Ctrl 100 CBP/p300 siRNA 80 P/CAF shRNA Pixel intentiy.-arbitrary units 60 40 ** ** ** ** 20 vehicle TSA

Supplementary figure 4 D. GFP-Scr CBP-p300 siRNA P/CAF shRNA GFP E. GFP-Scr +TSA 1ng/ml CBP-p300 siRNA +TSA 1ng/ml P/CAF shRNA +TSA 1ng/ml H3 AcK9-14 Hoechst

% of transfected neurons with cleaved Capspase 3 staining Supplementary figure 4 F. 50 40 30 % of transfected neurons with apoptotic features (fragmented or picnotic nuclei) 20 10 GFP-scr P/CAF shRNA CBP/p300 siRNA G. 50 40 % of transfected neurons with cleaved Capspase 3 staining 30 20 10 GFP-scr P/CAF shRNA CBP/p300 siRNA

Average neurite length/cell Supplementary figure 5 A. AcH3 K9-14 CBP Hoechst AcH3 K9-14 p300 Hoechst B. C. D. TSA TSA 140 80 Ctrl TSA 120 70 120 ** 60 100 100 Average neurite length/cell 50 Arbitrary Units 80 80 ** 40 Arbitrary Units 60 60 30 40 40 20 20 20 10 ** Ctrl TSA High Low High Low AcH3K9-14 AcH3K9-14

Supplementary figure 6 A. aTub1a SCG-10 Chl1 L1cam CAP-23 Lgals1 +1 -4000 -5000 -3000 -2000 -1000 p53 putative binding site Trans. starting site

** * * * * * ** * * Supplementary figure 6 B. a-Tubulin 1a Lcam1 SCG10 1 2 3 4 1 2 3 4 ** * Fold change TSA / vehicle Fold change TSA / vehicle Ctrl 4h 8h 24h Ctrl 4h 8h 24h SCG10 CAP 23 * 1 2 3 4 1 2 3 4 Fold change TSA / vehicle Fold change TSA / vehicle Ctrl 4h 8h 24h Ctrl 4h 8h 24h Chl1 Lgals1 1 2 3 4 1 2 3 4 * * ** * * * Fold change TSA / vehicle Fold change TSA / vehicle Ctrl 4h 8h 24h Ctrl 4h 8h 24h

% of transfected neurons with cleaved active caspase 3 positive cells Supplementary figure 7 A. 50 40 30 % of transfected neurons with apoptotic features (fragmented or pyknotic nuclei) 20 10 GFP p53 K-R B. 50 40 30 % of transfected neurons with cleaved active caspase 3 positive cells 20 10 GFP p53 K-R